Clinical Trials Browser

Phase 2 × INDUSTRY × Ibandronic Acid × Clear all

NCT00478270 2017-08-16

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Phase 2 Withdrawn

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT00502736 2014-01-22

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

Phase 2 Completed

Bone Neoplasms, Neoplasm Metastasis, Pain